EBNA1 has a predominant role in the maintenance of latent EBV infections and is expressed in all EBV infections and all EBV-associated malignant tissues. It contains a Gly-Ala repeated domain flanked by two unique regions. The central , C-terminus and N-terminus regions have been described as potentially antigenic.
REFERENCES
RAG0007 WB, DB, Indirect ELISA, positive control in direct ELISA, CLIA
GENE
BKRF1
DESCRIPTION
Late nuclear antigen
PURITY
>95% in a SDS-PAGE
SHIPPING AND STORAGE CONDITIONS
Proteins will be shipped on dry ice or ice pack. Upon arrival they should be stored at -20ºC to -80ºC. Avoid multiple freeze/thaw cycles
STABILITY
The protein will remain stable for four years if stored frozen
SPECIFICITY
The protein is immunoreactive against seropositive individuals to Epstein-Barr virus infection
IVD
Serodiagnosis of infectious mononucleosis associated to EBV and primary acute infections in immunocompromised individuals
SATISFACTION GUARANTEE
83% success rate in evaluations of recombinant antigen EBNA1 (RAG0007) for the development of a diagnostic assay
WB, DB, Indirect ELISA, positive control in direct ELISA, CLIA